Blog

A running collection of observations, research notes, and commentary on dermatology, skin health, and science that catches our attention at the clinic.

Blog

Drug-resistant ringworm is spreading worldwide — and our region is close to where it started

September 8, 2026

A drug-resistant ringworm fungus called Trichophyton indotineae has spread to at least 29 countries, with identifications tripling in three years. It shrugs off terbinafine — the standard ringworm pill — and causes large, intensely itchy rashes. It emerged from South Asia, so our region is very much in the picture. The single biggest thing making it worse: over-the-counter steroid-antifungal combination creams.

Read more →
Blog

Are we on the brink of reversing aging? The science of cellular reprogramming

August 6, 2026

Scientists can now take an old cell and reset its 'biological age' back toward youth — in the lab, and as of 2026, in the first human trial. It's some of the most exciting biology in medicine, and it sits right next to what aesthetic dermatology is all about: younger-looking, better-functioning skin. Here's the real science, and an honest line between promise and hype.

Read more →
Blog

The newest antifungal for tough cases is coming soon

July 27, 2026

A new antifungal drug called olorofim helped roughly three-quarters of patients with a severe, drug-resistant fungal infection (Valley fever) in a recent trial. What makes it exciting isn't just this one disease — it's that olorofim is the first antifungal with a genuinely new mechanism in about 20 years, which matters a great deal as fungal resistance keeps rising.

Read more →
Blog

Tregs — the immune system's peacekeepers, and a possible end to lifelong immunosuppressants

July 13, 2026

For decades, treating autoimmune disease or preventing transplant rejection has meant a lifetime on immunosuppressants — drugs that dampen the whole immune system and raise the risk of infection, cancer, and organ damage. A new class of therapy uses the body's own regulatory T cells (Tregs) to retrain immune tolerance precisely, where it's needed, without shutting everything down. The first Treg cell therapy just won FDA approval.

Read more →
Blog

Immune-cell nanodiscs that hunt down fungal infections

July 11, 2026

Researchers coated tiny biodegradable particles in the membrane of immune cells (macrophages), creating 'nanodiscs' that recognise Candida fungus the way a white blood cell would — then physically tear the fungal cell open. In infected mice they cleared fungus from organs and improved survival. A genuinely novel angle on the growing problem of drug-resistant fungal infection.

Read more →
Blog

Phage therapy, reframed — a three-stage model of phage-bacteria coexistence

July 2, 2026

Phages have long been pitched as 'living antibiotics' — viruses that kill bacteria we can no longer kill with drugs. A new framework argues that's too simple: phages and their bacterial hosts move through three different relationship stages, and only one of them looks like straightforward killing. What we do with phages therapeutically depends on which stage we're in.

Read more →
Blog

Why harmless soil fungi may become human pathogens — and how fast

February 10, 2026

Researchers at Kiel University have found that harmless soil fungi and their dangerous human-infecting cousins are genetically almost identical — the real difference is how fast they translate genes into fat-metabolising proteins. That makes the jump to becoming a human pathogen smaller than we thought.

Read more →